Evaluation of the Relationship Between Factor IX Inhibitor in Hemophilia B Patients and Different Types of Therapy in the North-eastern Part of Iran

Journal Title: Iranian Journal of Blood and Cancer - Year 2009, Vol 1, Issue 2

Abstract

Background: Hemophilia B is a bleeding disorder with a recessive X-linked inheritance pattern, in which the infected individuals have low levels of factor IX in their plasma. Affected individuals may have bleeding episodes after trauma or spontaneously considering the plasma level of factor IX. In order to prevent these episodes and to control bleeding, they should use coagulation factor concentrates that may be associated with the formation of inhibitors. Methods: This study was conducted in the northeast of Iran in 2006. Among 48 individuals who agreed to participate in our survey, 3 individuals (6.25%) had used FFP, 38 s (79.16%) factor IX concentrate and 7 (14.58 both FFP and factor IX concentrate in the 6 months prior to the study. Of them, three participants (6.3%) had factor IX inhibitor which was assayed using Bethesda method. Results: Three hemophilia B (6.3%) patients had factor IX inhibitor, but no correlation was found between the existence of the inhibitor and the type of coagulation therapy. Conclusion: Our findings did not show any correlation between factor IX inhibitor and type of coagulation therapy used in the 6 month period (p=0.65). None of the hemophiliacs had used coagulation factor as a prophylaxis regimen and most of them (83.33%) had injected coagulation factor on demand.

Authors and Affiliations

Hassan Mansouri Torghabeh, Aliakbar Pourfathollah, Mahmoud Mahmoudian Shoushtari

Keywords

Related Articles

Alkaline Phosphatase in Serum is a Marker of Human Toxocariasis

Background: The present study was carried out on the human population of Kashmir valley to evaluate the status of the biochemical parameters of infected population. Materials and Methods: Blood samples were collected fro...

Iran National Blood Transfusion Policy Goals, Objectives and Milestones for 2011-2015

Transfusion of blood and its components/derivatives is a life saving medical intervention. However, this life saving procedure depends mainly on the availability of sufficient blood and its components in national health...

Serum Antioxidant Levels in Children with Beta-Thalassemia Major

Background: Thalassemia represents a serious health problem in Iran because of its heterogeneous frequency and the existing endogamy system. It is an inherited blood disease characterized by the under production of norm...

Intravascular Hemolysis Due to Glucose‐6‐Phosphate Dehydrogenase Deficiency in a Patient with Aluminium Phosphide Poisoning

Aluminium Phosphide poisoning and glucose‐6‐phosphate dehydrogenase deficiency are two commonly seen clinical presentations in Iran. However, hemolysis associated with Aluminium Phosphide poisoning is very rare. We repor...

Download PDF file
  • EP ID EP383633
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Hassan Mansouri Torghabeh, Aliakbar Pourfathollah, Mahmoud Mahmoudian Shoushtari (2009). Evaluation of the Relationship Between Factor IX Inhibitor in Hemophilia B Patients and Different Types of Therapy in the North-eastern Part of Iran. Iranian Journal of Blood and Cancer, 1(2), 83-86. https://europub.co.uk/articles/-A-383633